MoHFW proposes extended deadline for compliance with revised Schedule M for small and medium scale manufacturers: public comments invited on draft Notification
In view of several representations to extend the timeline to enable small and medium scale... Read More
Reduced Custom Duty to nil and GST to 5% on three anti-cancer medicines, effective October 10, 2024, requiring price revisions by manufacturers
The National Pharmaceutical Pricing Authority (“NPPA”) has issued a Notification informing that... Read More
Union Health Ministry mandates registration of Clinical Research Organizations under New Drugs and Clinical Trials Amendment Rules, effective 1st April, 2025
The Union Health Ministry has notified the New Drugs and Clinical Trials (Amendment) Rules, 2024... Read More
Pharmaceuticals Department notifies revisions to sub-scheme ‘Revamped Pharmaceutical Technology Upgradation Assistance Scheme’: Increases incentive cap and simplifies application process for Pharma MSMEs
Department of Pharmaceuticals has notified modifications under the sub-scheme “Revamped... Read More